2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Poster Session

[P63] Poster Session 63 Lung Cancer/Thoracic Cancer(Perioperative)

[P63-5] Neoadjuvant osimertinib with/without chemotherapy vs chemotherapy for EGFR-mutated resectable NSCLC: NeoADAURA

Yasushi Yatabe1, Masahiro Tsuboi2, Walter Weder3, Carles Escriu4, Colli Blakely5, Jianxing He6, Sanja Dacic7, Lingmin Zeng8, Andrew Walding9, Jamie Chaft10 (1.Department of Diagnostic Pathology, National Cancer Center, 2.National Cancer Center Hospital East, 3.Thoraxchirurgie, Klinik Bethanien, Switzerland, 4.The Clatterbridge Cancer Centre, United Kingdom, 5.University of California, United States, 6.The First Affiliated Hospital of Guangzhou Medical University, China, 7.University of Pittsburgh Medical Center, United States, 8.AstraZeneca, United States, 9.AstraZeneca, United Kingdom, 10.Memorial Sloan Kettering Cancer Center, United States)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password